Application challenges of the new EU Clinical Trials Regulation Eugenijus GefenasAsta CekanauskaiteVilma Lukaseviciene Point of View 31 May 2017 Pages: 795 - 798
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field Malvina HoxhaG. Enrico RovatiAurora Bueno Cavanillas Review 04 April 2017 Pages: 799 - 809
Tolerability of new antiepileptic drugs: a network meta-analysis Gaetano ZaccaraFabio GiovannelliUmberto Benedetto Review 04 April 2017 Pages: 811 - 817
The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation Shelly LichtenbergRuth RahamimovBenaya Rozen-Zvi Clinical Trial 24 March 2017 Pages: 819 - 826
Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial Maria GustafssonMaria SjölanderHugo Lövheim Clinical Trial Open access 08 April 2017 Pages: 827 - 835
Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients Min Young BaekHan Sung HwangHye Sun Gwak Pharmacogenetics 08 April 2017 Pages: 837 - 842
Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease Yajing ZhaiHairong HeJun Lu Pharmacogenetics 05 April 2017 Pages: 843 - 854
Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions Kittika YampayonChonlaphat SukasemPornpimol Kijsanayotin Pharmacogenetics 08 April 2017 Pages: 855 - 865
Variation of antibiotic consumption and its correlated factors in Turkey Ayfer SahinAhmet AkiciAli Alkan Pharmacoepidemiology and Prescription 25 March 2017 Pages: 867 - 873
Comparative analysis of three drug–drug interaction screening systems against probable clinically relevant drug–drug interactions: a prospective cohort study Neža MuhičAles MrharMiran Brvar Pharmacoepidemiology and Prescription 15 March 2017 Pages: 875 - 882
Antidepressant use in suicides: a case-control study from the Friuli Venezia Giulia Region, Italy, 2005–2014 Giulio CastelpietraMichele GobbatoGöran Isacsson Pharmacoepidemiology and Prescription Open access 24 March 2017 Pages: 883 - 890
A global view of undergraduate education in pharmacovigilance Jenny HartmanLinda HärmarkEugène van Puijenbroek Pharmacoepidemiology and Prescription 17 March 2017 Pages: 891 - 899
From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006–2015: pharmacological perspectives on regulatory decisions Eva BarrenbergEdeltraut Garbe Pharmacoepidemiology and Prescription 28 March 2017 Pages: 901 - 910
Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine Kai-Ming JhangJing-Yang HuangYung-Po Liaw Pharmacoepidemiology and Prescription Open access 06 April 2017 Pages: 911 - 916
Erratum to: Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine Kai-Ming JhangJing-Yang HuangYung-Po Liaw Erratum 31 May 2017 Pages: 917 - 917
Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention Yan TangLingti KongXiaofei Wu Letter to the Editor 24 March 2017 Pages: 919 - 921
Tapering or abrupt cessation of proton pump inhibitors? Emily ReeveSarah Hilmer Letter to the Editor 22 March 2017 Pages: 923 - 924
Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity Malcolm BoyceFrans van den BergSteve Warrington Letter to the Editor 01 April 2017 Pages: 925 - 925
